Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Pilot Study to Evaluate the CellMist™ System in the Treatment of Deep Second Degree (IIoB) Burn Injuries With Autologous Skin Cells

NCT04890574 is registered in ClinicalTrials.gov with RenovaCare, Inc as lead sponsor.

NCT NCT04890574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04890574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Pilot Study to Evaluate the CellMist™ System in the Treatment of Deep Second Degree (IIoB) Burn Injuries With Autologous Skin Cells
Lead sponsor
RenovaCare, Inc
Phase
Phase 1
Overall status
Unknown status
Start date
May 26, 2021
Completion date
November 30, 2022
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burns, burns deep second degree, burns second degree